4D Molecular Therapeutics, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2021
Total Assets: $353.5M
Liabilities Breakdown FY2021
Total Liabilities: $34.4M
Asset Breakdown
Total Assets: $353.5M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $153.0M | 43.3% |
| Accounts Receivable | $47.0K | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $14.4M | 4.1% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $186.0M | 52.6% |
Liabilities Breakdown
Total Liabilities: $34.4M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $4.8M | 13.9% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $29.6M | 86.1% |